Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Pubblicazioni
Progetti
Persone
Terza Missione
Competenze
Settori
Strutture
IT
EN
☰
UNI-FIND
|
UNI-FIND
unito.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Pubblicazioni
Progetti
Persone
Terza Missione
Competenze
Settori
Strutture
☰
Pubblicazioni
BLOOD CANCER JOURNAL
Rivista
Codice:
E205920
ISSN:
2044-5385
Dati Generali
Dati Generali
Pubblicazioni (19)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.
Articolo
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells
Articolo
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
Articolo
CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies
Articolo
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
Articolo
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
Articolo
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib
Articolo
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
Articolo
Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
Articolo
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial
Articolo
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials
Articolo
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life
Articolo
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
Articolo
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
Articolo
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
Articolo
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients
Articolo
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Articolo
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab
Articolo
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia.
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
